Nhu‐An Pham

3.2k total citations
56 papers, 1.8k citations indexed

About

Nhu‐An Pham is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nhu‐An Pham has authored 56 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 25 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nhu‐An Pham's work include Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (9 papers) and Cancer Research and Treatments (7 papers). Nhu‐An Pham is often cited by papers focused on Lung Cancer Treatments and Mutations (15 papers), Cancer Genomics and Diagnostics (9 papers) and Cancer Research and Treatments (7 papers). Nhu‐An Pham collaborates with scholars based in Canada, United States and Japan. Nhu‐An Pham's co-authors include David W. Hedley, Ming‐Sound Tsao, Joerg Schwock, Brian H. Robinson, Aaron D. Schimmer, Frances A. Shepherd, Vladimir V. Iakovlev, Geoffrey Liu, Pinjiang Cao and Jcm Ho and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Nhu‐An Pham

54 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nhu‐An Pham Canada 24 980 660 381 369 172 56 1.8k
Wendy J. Huss United States 22 981 1.0× 711 1.1× 497 1.3× 664 1.8× 202 1.2× 40 1.8k
Chandra Bartholomeusz United States 24 1.2k 1.2× 867 1.3× 416 1.1× 321 0.9× 155 0.9× 44 2.0k
Kristina Viktorsson Sweden 27 1.5k 1.6× 637 1.0× 469 1.2× 232 0.6× 139 0.8× 70 2.2k
An Wouters Belgium 27 1.1k 1.1× 965 1.5× 497 1.3× 388 1.1× 355 2.1× 73 2.2k
Yiding Chen China 21 975 1.0× 710 1.1× 526 1.4× 247 0.7× 145 0.8× 86 2.0k
Sven A. Lang Germany 24 928 0.9× 449 0.7× 298 0.8× 174 0.5× 218 1.3× 44 1.5k
Helena Pópulo Portugal 13 1.2k 1.2× 518 0.8× 344 0.9× 188 0.5× 250 1.5× 21 1.9k
Jennifer L. Wilding United Kingdom 17 974 1.0× 767 1.2× 467 1.2× 183 0.5× 144 0.8× 24 1.9k
Christophe Deben Belgium 20 652 0.7× 617 0.9× 301 0.8× 240 0.7× 255 1.5× 49 1.5k
Leanne de Koning France 27 1.5k 1.6× 486 0.7× 445 1.2× 379 1.0× 164 1.0× 66 2.3k

Countries citing papers authored by Nhu‐An Pham

Since Specialization
Citations

This map shows the geographic impact of Nhu‐An Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nhu‐An Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nhu‐An Pham more than expected).

Fields of papers citing papers by Nhu‐An Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nhu‐An Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nhu‐An Pham. The network helps show where Nhu‐An Pham may publish in the future.

Co-authorship network of co-authors of Nhu‐An Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Nhu‐An Pham. A scholar is included among the top collaborators of Nhu‐An Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nhu‐An Pham. Nhu‐An Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Pinjiang, Nhu‐An Pham, Matthew Waas, et al.. (2025). Modeling response to the KRAS-G12C inhibitor AZD4625 in KRASG12C NSCLC patient-derived xenografts reveals insights into primary resistance mechanisms. British Journal of Cancer. 134(1). 165–174.
2.
Pham, Nhu‐An, Ziyuan Wang, Giulia Corradetti, et al.. (2025). Automated Foveal Avascular Zone Segmentation in Optical Coherence Tomography Angiography Across Multiple Eye Diseases Using Knowledge Distillation. Bioengineering. 12(4). 334–334. 3 indexed citations
3.
Park, Cheol‐Kyu, Nhu‐An Pham, Stephanie M. Wong, et al.. (2024). Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research. JTO Clinical and Research Reports. 6(3). 100781–100781. 2 indexed citations
4.
Ubhi, Tajinder, Olga Zaslaver, Andrew T. Quaile, et al.. (2024). Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells. Nature Cancer. 5(6). 895–915. 12 indexed citations
5.
Moghal, Nadeem, Quan Li, Erin Stewart, et al.. (2022). Single-Cell Analysis Reveals Transcriptomic Features of Drug-Tolerant Persisters and Stromal Adaptation in a Patient-Derived EGFR-Mutated Lung Adenocarcinoma Xenograft Model. Journal of Thoracic Oncology. 18(4). 499–515. 32 indexed citations
6.
Weiss, Jessica, Nhu‐An Pham, Sebastião N. Martins-Filho, et al.. (2021). Antitumor efficacy of XPO1 inhibitor Selinexor in KRAS-mutant lung adenocarcinoma patient-derived xenografts. Translational Oncology. 14(10). 101179–101179. 16 indexed citations
7.
Tong, Jiefei, Jonathan R. Krieger, Paul Taylor, et al.. (2020). Cancer proteome and metabolite changes linked to SHMT2. PLoS ONE. 15(9). e0237981–e0237981. 15 indexed citations
8.
Shi, Ruoshi, Nikolina Radulovich, Christine Ng, et al.. (2019). Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(5). 1162–1174. 204 indexed citations
9.
Wang, Dennis, Nhu‐An Pham, Timothy M. Freeman, et al.. (2019). Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer. Cancers. 11(7). 1009–1009. 4 indexed citations
10.
Shi, Ruoshi, Ming Li, Vibha Raghavan, et al.. (2018). Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA -Mutant Lung Squamous Cell Carcinoma. Clinical Cancer Research. 24(23). 5990–6000. 20 indexed citations
11.
Shi, Ruoshi, Marileila Varella‐Garcia, Ming Li, et al.. (2016). An Anaplastic Lymphoma Kinase Immunohistochemistry–Negative but Fluorescence In Situ Hybridization–Positive Lung Adenocarcinoma Is Resistant to Crizotinib. Journal of Thoracic Oncology. 11(12). 2248–2252. 4 indexed citations
12.
Martin, Petra, Erin Stewart, Nhu‐An Pham, et al.. (2016). Cetuximab Inhibits T790M-Mediated Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in a Lung Adenocarcinoma Patient-Derived Xenograft Mouse Model. Clinical Lung Cancer. 17(5). 375–383.e2. 11 indexed citations
13.
Wei, Yuhong, Ravi N. Vellanki, Étienne Coyaud, et al.. (2015). CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration. Molecular Cancer Research. 13(7). 1119–1129. 47 indexed citations
14.
15.
Nakajima, Takahiro, William R. Geddie, Takashi Anayama, et al.. (2015). Patient-derived tumor xenograft models established from samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration. Lung Cancer. 89(2). 110–114. 13 indexed citations
16.
Radulovich, Nikolina, Nhu‐An Pham, Dan Strumpf, et al.. (2010). Differential roles of cyclin D1 and D3 in pancreatic ductal adenocarcinoma. Molecular Cancer. 9(1). 24–24. 33 indexed citations
17.
Sridhar, Srikala S., Sébastien J. Hotte, Joseph L. Chin, et al.. (2010). A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer. American Journal of Clinical Oncology. 33(6). 609–613. 56 indexed citations
18.
Pham, Nhu‐An, Trevor Do, Joerg Schwock, et al.. (2008). Activation of Src and Src‐associated signaling pathways in relation to hypoxia in human cancer xenograft models. International Journal of Cancer. 124(2). 280–286. 25 indexed citations
19.
Pham, Nhu‐An, Joerg Schwock, Sarit Aviel‐Ronen, et al.. (2007). Quantitative image analysis of immunohistochemical stains using a CMYK color model. Diagnostic Pathology. 2(1). 8–8. 140 indexed citations
20.
Schimmer, Aaron D., David W. Hedley, Nhu‐An Pham, Sue Chow, & Mark D. Minden. (2001). BAD Induces Apoptosis in Cells Over-Expressing Bcl-2 or Bcl-xL without Loss of Mitochondrial Membrane Potential. Leukemia & lymphoma. 42(3). 429–443. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy J. Huss Breakdown of academic impact, for papers by Chandra Bartholomeusz Breakdown of academic impact, for papers by Kristina Viktorsson Breakdown of academic impact, for papers by An Wouters Breakdown of academic impact, for papers by Yiding Chen Breakdown of academic impact, for papers by Sven A. Lang Breakdown of academic impact, for papers by Helena Pópulo Breakdown of academic impact, for papers by Jennifer L. Wilding Breakdown of academic impact, for papers by Christophe Deben Breakdown of academic impact, for papers by Leanne de Koning
Rankless by CCL
2026